Auf dieser Seite
TVTX Travere Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 4, 2026
$56,93
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$23,0052-Wochen-Tief
$68,7352-Wochen-Hoch
Marktkapitalisierung (MRQ)
$5.36B
P/E (TTM)
-126.5
EPS (TTM)
$-0.45
Umsatz (TTM)
$591M
Ihre Abzeichen
52W-Spanne
$23–$69
Analystenbewertung
BUY
Kursziel
$75
P/E
-126.5
ROE
-151.8%
Nettogewinnmarge
-7.4%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
TVTX Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$56.93
Marktkapitalisierung (MRQ)
$5.36B
P/E (TTM)
-126.5
EPS (TTM)
$-0.45
Umsatz (TTM)
$591M
ROE (TTM)
-151.8%
52W-Spanne
$23–$69
TVTX Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$491M2016-12-31 → 2025-12-31
EPS$-0.292016-12-31 → 2025-12-31
Freier Cashflow·2016-12-31 → 2023-12-31
Nettogewinnmarge-7.4%2016-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | TVTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -126.55-Jahres-Durchschnitt ≈-31.4 | ≈-31.4 | · | · | |
| P/S (TTM) | 9.15-Jahres-Durchschnitt ≈9.1 | ≈9.1 | 18.5 | Unterbewertet | |
| K/B (MRQ) | 218.65-Jahres-Durchschnitt ≈19.5 | ≈19.5 | 12.5 | Überbewertet | |
| Price / Cash Flow (Kurs / Cashflow) | 137.05-Jahres-Durchschnitt ≈-11.1 | ≈-11.1 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | -50.15-Jahres-Durchschnitt ≈1212.9 | ≈1212.9 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | TVTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -6.8%5-Jahres-Durchschnitt ≈-123.2% | ≈-123.2% | -24.1% | Spitzenklasse | |
| EBITDA-Marge (TTM) | 3.9%5-Jahres-Durchschnitt ≈-106.2% | ≈-106.2% | -24.1% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | -11.3%5-Jahres-Durchschnitt ≈-123.3% | ≈-123.3% | -28.9% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | -7.4%5-Jahres-Durchschnitt ≈-86.1% | ≈-86.1% | -38.1% | Spitzenklasse | |
| ROA (TTM) | -6.4%5-Jahres-Durchschnitt ≈-26.1% | ≈-26.1% | -23.8% | Spitzenklasse | |
| ROE (TTM) | -151.8%5-Jahres-Durchschnitt ≈-555.0% | ≈-555.0% | -35.7% | Im Einklang | |
| ROIC | -55.8%5-Jahres-Durchschnitt ≈-294.8% | ≈-294.8% | -16.7% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | TVTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 4.05-Jahres-Durchschnitt ≈3.3 | ≈3.3 | 8.3 | Geringe Liquidität | |
| Quick Ratio | 1.15-Jahres-Durchschnitt ≈0.8 | ≈0.8 | 3.2 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | TVTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 110.5%5-Jahres-Durchschnitt ≈30.6% | ≈30.6% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 64.9%5-Jahres-Durchschnitt ≈25.3% | ≈25.3% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 19.9% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | TVTX | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.85-Jahres-Durchschnitt ≈0.4 | ≈0.4 | 0.0 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 0.35-Jahres-Durchschnitt ≈1.0 | ≈1.0 | · | · | |
| Receivables Turnover (Forderungsumschlag) | 9.25-Jahres-Durchschnitt ≈10.8 | ≈10.8 | 9.2 | Im Einklang | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$987.4K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
67.9%
Nächster Bericht
Okt 28, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 4, 2026 | $-0.10 | $-0.14 | 29.3% |
| 31. März 2026 | $-0.40 | $-0.27 | -47.7% | |
| 31. Dezember 2025 | $0.03 | $-0.12 | 124.9% | |
| 30. September 2025 | $0.28 | $-0.21 | 232.1% | |
| 30. Juni 2025 | $-0.14 | $-0.30 | 53.9% | |
| 31. März 2025 | $-0.47 | $-0.55 | 14.7% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $491M | $233M | $145M | $109M | $132M | $198M | $175M | $164M | $155M | $134M | $100M | $28M | |
| Cost of Revenue | $10M | $8M | $11M | $4M | $4M | $6M | $5M | $6M | $4M | $5M | $2M | $571.0K | |
| R&D Expense | · | · | · | $8M | · | · | $141M | $124M | $78M | $71M | $50M | $48M | |
| SG&A Expense | $337M | $264M | $266M | $198M | $126M | $136M | $129M | $104M | $101M | $92M | $80M | $60M | |
| Operating Expenses | $554M | $557M | $533M | $429M | $331M | $374M | $313M | $244M | $209M | $192M | $151M | $108M | |
| Operating Income | $-63M | $-324M | $-388M | $-320M | $-199M | $-176M | $-137M | $-80M | $-54M | $-58M | $-51M | $-80M | |
| Interest Expense | · | · | $11M | $11M | $20M | $19M | $19M | $10M | $4M | $5M | $8M | $7M | |
| Interest Income | $13M | $18M | $22M | $6M | $2M | $5M | $10M | $5M | $3M | · | · | · | |
| Other Non-op | $12M | $-3M | $2M | $974.0K | $231.0K | $1M | $-314.0K | $-474.0K | $1M | $-264.0K | $-296.0K | $2M | |
| Pretax Income | $-49M | $-321M | $-376M | $-331M | $-217M | $-189M | $-146M | $-102M | $-58M | $-58M | $105M | $-113M | |
| Income Tax | $988.0K | $120.0K | $223.0K | $313.0K | $409.0K | $-19M | $-21.0K | $811.0K | $1M | $-10M | $-12M | $-2M | |
| Net Income | $-26M | $-322M | $-111M | $-278M | $-180M | $-169M | $-146M | $-103M | $-60M | $-48M | $117M | $-111M | |
| EPS (Basic) | $-0.29 | $-4.08 | $-1.50 | $-4.37 | $-3.01 | $-3.56 | $-3.46 | $-2.54 | $-1.54 | $-1.29 | $3.49 | $-4.43 | |
| EPS (Diluted) | $-0.29 | $-4.08 | $-1.50 | $-4.37 | $-3.01 | $-3.56 | $-3.46 | $-2.54 | $-1.54 | $-1.29 | $3.17 | $-4.43 | |
| Shares (Basic) | 89,211,813 | 78,888,861 | 74,267,418 | 63,758,515 | 59,832,287 | 47,539,631 | 42,339,961 | 40,433,171 | 38,769,816 | 36,997,865 | 33,560,249 | 25,057,509 | |
| Shares (Diluted) | 89,211,813 | 78,888,861 | 74,267,418 | 63,758,515 | 59,832,287 | 47,539,631 | 42,339,961 | 40,433,171 | 38,769,816 | 38,288,012 | 37,581,439 | 25,057,509 | |
| EBITDA | $-2M | $-280M | $-350M | $-233M | $-135M | $-152M | $-117M | $-61M | $-36M | $-42M | · | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $93M | $59M | $58M | $62M | $166M | $85M | $62M | $103M | $99M | $41M | $38M | $18M | |
| Short-term Investments | · | · | · | · | · | · | · | · | $201M | $215M | $192M | $10M | |
| Receivables | $80M | $27M | $21M | $17M | $16M | $16M | $18M | $13M | $14M | $19M | $12M | $8M | |
| Inventory | $36M | $42M | $9M | $5M | $7M | $8M | $6M | $6M | $5M | $3M | $3M | $801.0K | |
| Prepaid Expense | $29M | $13M | $19M | $12M | $7M | $8M | $5M | $4M | $3M | $5M | $2M | $813.0K | |
| Current Assets | $438M | $417M | $617M | $486M | $583M | $410M | $429M | $496M | $326M | $332M | $302M | $37M | |
| PP&E (Net) | $4M | $5M | $7M | $9M | $11M | $9M | $3M | $3M | $3M | $3M | $428.0K | $671.0K | |
| PP&E (Gross) | $14M | $14M | $15M | $14M | $14M | $13M | $5M | $4M | $4M | $3M | · | · | |
| Accum. Depreciation | $10M | $9M | $7M | $5M | $3M | $4M | $2M | $1M | $585.0K | $200.0K | · | · | |
| Goodwill | · | $800.0K | $800.0K | $800.0K | $900.0K | $900.0K | $936.0K | $936.0K | $936.0K | $936.0K | $936.0K | $936.0K | |
| Intangibles | $114M | $104M | $104M | $97M | $148M | $154M | $157M | $187M | $185M | $182M | $162M | $94M | |
| Other Non-current Assets | $9M | $18M | $11M | $11M | $11M | $8M | $15M | $8M | $6M | $7M | $2M | $2M | |
| Total Assets | $605M | $594M | $789M | $673M | $777M | $607M | $605M | $709M | $520M | $525M | $512M | $135M | |
| Accounts Payable | $25M | $24M | $42M | $17M | $15M | $12M | $27M | $7M | $19M | $8M | $8M | $7M | |
| Accrued Liabilities | $126M | $86M | $119M | $96M | $75M | $57M | $52M | $50M | $36M | $33M | $24M | $28M | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | · | $0 | $40M | |
| Current Liabilities | $160M | $201M | $178M | $142M | $124M | $93M | $95M | $105M | $86M | $83M | $87M | $108M | |
| Capital Leases | $11M | $17M | $23M | $28M | $31M | $28M | $7M | · | · | · | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | $0 | $6M | $24M | $141.0K | |
| Other Non-current Liabilities | $8M | $7M | $10M | $9M | $12M | $12M | $21M | $18M | $2M | $4M | $3M | $2M | |
| Total Liabilities | $490M | $535M | $588M | $630M | $475M | $396M | $384M | $391M | $227M | $218M | $212M | $173M | |
| Common Stock | $9.0K | $9.0K | $7.0K | $6.0K | $6.0K | $5.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | |
| Paid-in Capital | $1.59B | $1.51B | $1.33B | $1.06B | $1.07B | $798M | $637M | $590M | $472M | $421M | $366M | $141M | |
| Retained Earnings | $-1.47B | $-1.45B | $-1.13B | $-1.01B | $-766M | $-586M | $-416M | $-270M | $-178M | $-113M | $-65M | $-179M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | $0 | $3M | |
| AOCI | $-1M | $-80.0K | $-1M | $-3M | $-562.0K | $-902.0K | $726.0K | $-2M | $-1M | $-490.0K | $-682.0K | $4M | |
| Stockholders' Equity | $115M | $59M | $201M | $43M | $302M | $211M | $221M | $318M | $293M | $308M | $300M | $-37M | |
| Liabilities + Equity | $605M | $594M | $789M | $673M | $777M | $607M | $605M | $709M | $520M | $525M | $512M | $135M | |
| Shares Outstanding | 90,922,868 | 87,452,835 | 75,367,117 | 64,290,570 | 62,491,498 | 52,248,431 | 43,088,921 | 41,389,524 | 39,373,745 | 37,906,669 | 36,465,853 | 26,048,480 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $61M | $44M | $39M | $21M | $13M | $25M | $20M | $19M | $18M | $16M | $13M | $5M | |
| Stock-based Comp | $45M | $37M | $44M | $38M | $30M | $24M | $21M | $20M | $27M | $29M | $26M | $16M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-6M | $-23M | $-16M | $-2M | |
| Amort. of Intangibles | $59M | $42M | $36M | $19M | $11M | $22M | $20M | $18M | $17M | $16M | $13M | $5M | |
| Restructuring | $0 | $2M | $11M | $0 | $0 | $0 | $0 | $-242.0K | $4M | $893.0K | $0 | · | |
| Other Non-cash | $-42M | $4M | $-251M | $20M | $108M | $78M | $47M | $39M | $29M | $24M | · | · | |
| Operating Cash Flow | $38M | $-237M | $-280M | $-186M | $-15M | $-43M | $-58M | $-25M | $7M | $-3M | $-1M | $-46M | |
| CapEx | · | · | $668.0K | $191.0K | $5M | $7M | $195.0K | $727.0K | $887.0K | $1M | $22.0K | $663.0K | |
| Investing Cash Flow | $28M | $99M | $56M | $-33M | $-138M | $-61M | $20M | $-203M | $46M | $10M | $-81M | · | |
| Net Debt Issued | · | · | · | · | · | $0 | $0 | $-40M | · | · | · | · | |
| Stock Issued | $0 | $135M | $191M | $0 | $189M | · | · | · | $0 | $0 | $149M | $40M | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | $0 | $0 | $2M | |
| Net Stock Activity | $0 | $135M | $191M | · | · | · | · | · | $0 | $0 | · | · | |
| Financing Cash Flow | $-33M | $139M | $219M | $118M | $232M | $128M | $-2M | $232M | $5M | $-4M | $102M | $95M | |
| Net Change in Cash | $34M | $359.0K | $-4M | $-104M | $81M | $22M | $-40M | $3M | $58M | $3M | $20M | $12M | |
| Taxes Paid | · | $453.0K | $578.0K | $996.0K | $-16M | $-3M | $656.0K | $218.0K | · | · | · | · | |
| Free Cash Flow | · | · | $-281M | $-186M | $-20M | $-50M | $-58M | $-26M | $7M | $-3M | · | · | |
| Levered FCF | · | · | $-292M | $-198M | $-40M | $-67M | $-77M | $-36M | $5M | $-4M | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -12.8% | -138.9% | -267.2% | -125.7% | -71.1% | -88.8% | -78.3% | -48.7% | -34.7% | -43.6% | · | · | |
| Net Margin | -5.2% | -137.9% | -76.7% | -131.3% | -79.2% | -85.4% | -83.5% | -62.5% | -38.6% | -35.9% | · | · | |
| Pretax Margin | -10.0% | -137.5% | -259.0% | -131.2% | -79.0% | -95.2% | -83.5% | -62.0% | -37.7% | -43.1% | · | · | |
| EBITDA Margin | -0.42% | -120.2% | -240.7% | -110.1% | -59.4% | -76.4% | -66.7% | -37.4% | -23.2% | -31.5% | · | · | |
| ROA | -4.3% | -46.5% | -15.2% | -38.4% | -26.0% | -28.0% | -22.3% | -16.7% | · | -9.2% | · | · | |
| ROE | -34.6% | -2246.8% | -46.4% | -388.1% | -59.1% | -66.1% | -62.7% | -32.2% | · | -15.8% | · | · | |
| ROIC | -55.8% | -548.4% | -193.4% | -622.8% | -53.7% | -74.9% | -62.1% | -25.4% | · | -15.7% | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.7 | 2.1 | 3.5 | 3.4 | 4.7 | 4.4 | 4.5 | 4.7 | · | 4.0 | · | · | |
| Quick Ratio | 1.1 | 0.4 | 0.4 | 0.6 | 1.5 | 1.1 | 0.8 | 1.1 | · | 3.3 | · | · | |
| Interest Coverage | · | · | -34.3 | -23.6 | -8.0 | -9.2 | -7.3 | -8.2 | -44.8 | -72.8 | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 | 0.3 | 0.3 | · | 0.3 | · | · | |
| Inventory Turnover | 0.3 | 1.0 | 1.6 | 1.1 | 0.9 | 0.9 | 0.9 | 1.0 | · | 1.7 | · | · | |
| Receivables Turnover | 9.2 | 9.7 | 7.7 | 13.0 | 14.3 | 11.7 | 11.4 | 11.6 | · | 8.6 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.26 | $0.68 | $2.66 | $0.67 | $4.83 | $4.04 | $5.13 | $7.69 | · | $8.12 | · | · | |
| Revenue / Share | $5.50 | $2.96 | $1.96 | $3.33 | $3.80 | · | · | $4.06 | $4.00 | $3.49 | · | · | |
| Cash Flow / Share | $0.42 | $-3.01 | $-3.77 | $-2.92 | $-0.25 | · | · | $-0.62 | $0.19 | $-0.04 | · | · | |
| Cash / Share | $1.02 | $0.67 | $0.77 | $0.96 | $2.65 | $1.62 | $1.45 | $2.49 | · | $1.08 | · | · | |
| EPS (TTM) | $-0.29 | $-4.08 | $-1.50 | $-4.37 | $-3.01 | $-3.56 | $-3.46 | $-2.54 | $-1.54 | $-1.29 | $3.17 | $-4.43 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 110.5% | 60.6% | 32.7% | -17.0% | -33.5% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 64.9% | 20.9% | -9.9% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 19.9% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $491M | $233M | $145M | $109M | $132M | $198M | $175M | $164M | $155M | $134M | $100M | $28M | |
| Net Income TTM | $-26M | $-322M | $-111M | $-278M | $-180M | $-169M | $-146M | $-103M | $-60M | $-48M | $117M | $-111M | |
| Market Cap | $3.47B | $1.52B | $678M | $1.35B | $1.94B | $1.42B | $612M | $937M | · | $718M | · | · | |
| P/E | -131.8 | -4.3 | -6.0 | -4.8 | -10.3 | -7.7 | -4.1 | -8.9 | -13.7 | -14.7 | 6.1 | -2.8 | |
| P/S | 7.1 | 6.5 | 4.7 | 12.4 | 14.7 | 7.2 | 3.5 | 5.7 | · | 5.4 | · | · | |
| P/B | 30.3 | 25.8 | 3.4 | 31.6 | 6.4 | 6.7 | 2.8 | 2.9 | · | 2.3 | · | · | |
| P / Tangible Book | 3618.9 | · | 7.1 | · | 12.7 | 25.3 | · | · | · | · | · | · | |
| P / Cash Flow | 91.9 | -6.4 | -2.4 | -7.3 | -131.1 | -33.3 | -10.5 | -37.5 | · | -449.6 | · | · | |
| P / FCF | · | · | -2.4 | -7.3 | -97.5 | -28.8 | -10.5 | -36.5 | · | -237.3 | · | · | |
| Earnings Yield | -0.76% | -23.4% | -16.7% | -20.8% | -9.7% | -13.1% | -24.4% | -11.2% | -7.3% | -6.8% | 16.4% | -36.2% |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $170M | $127M | $130M | $165M | $114M | $82M | $75M | $63M | $54M | $41M | $45M | $37M | $32M | $31M | $-21M | $28M | |
| Cost of Revenue | $2M | $2M | $3M | $2M | $2M | $5M | $3M | $2M | $2M | $2M | $5M | $1M | $1M | $4M | $-883.0K | $1M | |
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $8M | · | · | |
| SG&A Expense | $96M | $80M | $102M | $86M | $63M | $60M | $70M | $66M | $65M | $64M | $64M | $68M | $68M | $66M | $45M | $52M | |
| Operating Expenses | $166M | $164M | $162M | $140M | $127M | $124M | $136M | $119M | $122M | $181M | $139M | $130M | $136M | $128M | $84M | $111M | |
| Operating Income | $4M | $-37M | $-32M | $25M | $-13M | $-43M | $-61M | $-56M | $-68M | $-139M | $-94M | $-93M | $-104M | $-97M | $-106M | $-83M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $3M | · | $3M | $3M | $3M | · | $3M | |
| Interest Income | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $6M | $7M | $6M | $5M | $4M | $3M | $2M | |
| Other Non-op | $-169.0K | $-91.0K | $11M | $487.0K | $-526.0K | $549.0K | $-581.0K | $520.0K | $-3M | $238.0K | $1M | $335.0K | $-201.0K | $87.0K | $872.0K | $-586.0K | |
| Pretax Income | $-35M | $-37M | $-21M | $26M | $-13M | $-41M | $-60M | $-55M | $-70M | $-136M | $-89M | $-89M | $-102M | $-96M | $-104M | $-84M | |
| Income Tax | $-204.0K | $-120.0K | $921.0K | $8.0K | $20.0K | $39.0K | $-72.0K | $-84.0K | $85.0K | $191.0K | $68.0K | $12.0K | $65.0K | $78.0K | $63.0K | $145.0K | |
| Net Income | $-35M | $-37M | $3M | $26M | $-13M | $-41M | $-60M | $-55M | $-70M | $-136M | $-90M | $151M | $-86M | $-86M | $-66M | $-70M | |
| EPS (Basic) | $-0.37 | $-0.40 | $0.03 | $0.29 | $-0.14 | $-0.47 | $-0.71 | $-0.70 | $-0.91 | $-1.76 | $-1.07 | $1.97 | $-1.13 | $-1.27 | $-1.03 | $-1.09 | |
| EPS (Diluted) | $-0.37 | $-0.40 | $0.04 | $0.28 | $-0.14 | $-0.47 | $-0.71 | $-0.70 | $-0.91 | $-1.76 | $-1.07 | $1.97 | $-1.13 | $-1.27 | $-1.03 | $-1.09 | |
| Shares (Basic) | 93,479,416 | 91,868,862 | · | 89,230,420 | 88,945,624 | 88,355,973 | · | 77,779,379 | 77,500,245 | 77,136,493 | · | 76,305,603 | 76,001,801 | 68,174,099 | · | 64,033,759 | |
| Shares (Diluted) | 93,479,416 | 91,868,862 | · | 102,618,560 | 88,945,624 | 88,355,973 | · | 77,779,379 | 77,500,245 | 77,136,493 | · | 76,305,603 | 76,001,801 | 68,174,099 | · | 64,033,759 | |
| EBITDA | $4M | $-12M | · | $25M | $-13M | $-30M | · | $-56M | $-68M | $-129M | · | $-93M | $-88M | $-78M | · | $-68M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $118M | $78M | $93M | $111M | $75M | $62M | $59M | $36M | $32M | $43M | · | $144M | $71M | $161M | · | $151M | |
| Receivables | $81M | $87M | $80M | $83M | $39M | $34M | $27M | $25M | $24M | $23M | · | $15M | $20M | $22M | · | $13M | |
| Inventory | $40M | $37M | $36M | $38M | $38M | $38M | $42M | $43M | $43M | $42M | · | $21M | $19M | $7M | · | $7M | |
| Prepaid Expense | $37M | $34M | $29M | $28M | $17M | $14M | $13M | $16M | $13M | $13M | · | $16M | $12M | $15M | · | $9M | |
| Current Assets | $615M | $393M | $438M | $371M | $380M | $374M | $417M | $325M | $369M | $481M | · | $686M | $542M | $605M | · | $535M | |
| PP&E (Net) | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $6M | $7M | $7M | · | $8M | $9M | $9M | · | $10M | |
| PP&E (Gross) | · | · | $14M | · | · | · | $14M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $10M | · | · | · | $9M | · | · | · | · | · | · | · | · | · | |
| Goodwill | · | · | · | $800.0K | $800.0K | $800.0K | · | $800.0K | $800.0K | $800.0K | · | $800.0K | $900.0K | $900.0K | · | $900.0K | |
| Intangibles | $132M | $110M | $114M | $109M | $106M | $104M | $104M | $104M | $105M | $101M | · | $107M | $154M | $163M | · | $149M | |
| Other Non-current Assets | $9M | $8M | $9M | $10M | $20M | $19M | $18M | $17M | $17M | $19M | · | $13M | $12M | $11M | · | $11M | |
| Total Assets | $799M | $555M | $605M | $539M | $555M | $549M | $594M | $504M | $551M | $664M | · | $833M | $736M | $808M | · | $726M | |
| Accounts Payable | $7M | $13M | $25M | $18M | $19M | $15M | $24M | $23M | $26M | $17M | · | $25M | $20M | $17M | · | $14M | |
| Accrued Liabilities | $136M | $104M | $126M | $106M | $82M | $77M | $86M | $84M | $80M | $140M | · | $96M | $89M | $86M | · | $88M | |
| Current Liabilities | $152M | $125M | $160M | $135M | $190M | $182M | $201M | $190M | $121M | $173M | · | $139M | $136M | $131M | · | $131M | |
| Capital Leases | $8M | $10M | $11M | $13M | $14M | $16M | $17M | $19M | $20M | $21M | · | $24M | $25M | $26M | · | $28M | |
| Other Non-current Liabilities | $12M | $9M | $8M | $6M | $8M | $7M | $7M | $16M | $17M | $16M | · | $8M | $9M | $9M | · | $9M | |
| Total Liabilities | $775M | $456M | $490M | $465M | $523M | $516M | $535M | $535M | $536M | $589M | · | $553M | $620M | $619M | · | $626M | |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | · | $7.0K | $7.0K | $7.0K | · | $6.0K | |
| Paid-in Capital | $1.57B | $1.61B | $1.59B | $1.55B | $1.53B | $1.52B | $1.51B | $1.36B | $1.35B | $1.34B | · | $1.32B | $1.31B | $1.29B | · | $1.05B | |
| Retained Earnings | $-1.54B | $-1.51B | $-1.47B | $-1.48B | $-1.50B | $-1.49B | $-1.45B | $-1.39B | $-1.33B | $-1.26B | · | $-1.04B | $-1.19B | $-1.10B | · | $-948M | |
| AOCI | $-1M | $-1M | $-1M | $-1M | $-812.0K | $-843.0K | $-80.0K | $-1M | $-2M | $-2M | · | $-4M | $-4M | $-2M | · | $303.0K | |
| Stockholders' Equity | $25M | $99M | $115M | $74M | $33M | $33M | $59M | $-30M | $15M | $74M | $201M | $280M | $116M | $189M | $43M | $101M | |
| Liabilities + Equity | $799M | $555M | $605M | $539M | $555M | $549M | $594M | $504M | $551M | $664M | · | $833M | $736M | $808M | · | $726M | |
| Shares Outstanding | 94,174,767 | 92,403,744 | 90,922,868 | 89,456,626 | 89,102,347 | 88,787,429 | 87,452,835 | 77,909,042 | 76,456,562 | 76,108,829 | · | 75,111,517 | 74,971,807 | 74,586,806 | · | 64,150,510 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $25M | $18M | $16M | $14M | $13M | $12M | $11M | $10M | $10M | $9M | $6M | $8M | $7M | $6M | $-793.0K | |
| Stock-based Comp | $22M | $16M | $11M | $11M | $11M | $11M | $9M | $8M | $10M | $10M | $8M | $11M | $11M | $13M | $9M | $8M | |
| Amort. of Intangibles | $4M | $25M | $18M | $15M | $14M | $12M | $12M | $11M | $10M | $9M | $9M | $11M | $10M | $6M | $-603.0K | $5M | |
| Restructuring | · | · | $0 | $0 | $0 | $0 | $1M | $123.0K | $653.0K | $259.0K | $11M | $0 | $0 | $0 | · | · | |
| Other Non-cash | · | $-45M | · | · | · | $-25M | · | · | · | $-3M | · | · | · | $-18M | · | · | |
| Operating Cash Flow | $58M | $-40M | $61M | $14M | $5M | $-42M | $-36M | $-43M | $-40M | $-119M | $-70M | $-59M | $-69M | $-81M | $-55M | $-40M | |
| CapEx | · | · | · | $140.0K | · | · | · | $0 | $82.0K | $0 | · | $10.0K | $3.0K | $630.0K | · | $13.0K | |
| Investing Cash Flow | $-206M | $22M | $-105M | $87M | $5M | $41M | $-80M | $46M | $29M | $105M | $-17M | $133M | $-24M | $-37M | $-37M | $10M | |
| Financing Cash Flow | $188M | $4M | $27M | $-65M | $1M | $4M | $139M | $46.0K | $782.0K | $-525.0K | $124.0K | $-634.0K | $2M | $217M | $551.0K | $2M | |
| Net Change in Cash | $39M | $-15M | $-18M | $36M | $13M | $3M | $22M | $4M | $-11M | $-15M | $-86M | $73M | $-91M | $100M | $-90M | $-28M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-119M | · | · | · | $-82M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-122M | · | · | · | $-85M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 2.3% | -29.0% | · | 15.1% | -11.1% | -52.2% | · | -89.3% | -125.1% | -336.5% | · | -249.6% | -146.7% | -152.7% | · | -127.4% | |
| Net Margin | -20.5% | -29.2% | · | 15.6% | -11.1% | -50.4% | · | -87.1% | -130.1% | -328.9% | · | 406.4% | -143.4% | -151.5% | · | -130.2% | |
| Pretax Margin | -20.6% | -28.9% | · | 15.6% | -11.1% | -50.4% | · | -87.2% | -128.6% | -328.1% | · | -240.5% | -143.3% | -151.3% | · | -129.9% | |
| EBITDA Margin | 2.3% | -9.2% | · | 15.1% | -11.1% | -36.5% | · | -89.3% | -125.1% | -312.6% | · | -249.6% | -146.7% | -136.0% | · | -127.4% | |
| ROA | -5.1% | -6.7% | · | 4.9% | -2.3% | -6.8% | · | -8.2% | -10.9% | -18.5% | · | 19.3% | -11.3% | -10.5% | · | -9.3% | |
| ROE | -121.5% | -56.4% | · | 119.3% | -53.3% | -77.1% | · | -44.0% | -107.0% | -103.4% | · | 79.2% | -62.7% | -43.5% | · | -34.1% | |
| ROIC | 16.0% | -37.3% | · | 33.9% | -38.7% | -130.1% | · | 184.1% | -447.5% | -188.2% | · | -33.1% | -75.2% | -46.1% | · | -67.8% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.0 | 3.1 | · | 2.7 | 2.0 | 2.1 | · | 1.7 | 3.0 | 2.8 | · | 4.9 | 4.0 | 4.6 | · | 4.1 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.4 | 0.6 | 0.5 | · | 0.3 | 0.5 | 0.4 | · | 1.1 | 0.7 | 1.4 | · | 1.3 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -49.7 | · | -33.1 | -30.2 | -30.0 | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.2 | · | 0.3 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.1 | 0.1 | · | 0.0 | 0.0 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.2 | 0.8 | · | 0.2 | |
| Receivables Turnover | 2.8 | 2.1 | · | 3.0 | 3.6 | 2.9 | · | 3.2 | 2.4 | 1.9 | · | 2.7 | 3.2 | 3.1 | · | 4.1 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.26 | $1.07 | · | $0.82 | $0.37 | $0.37 | · | $-0.39 | $0.20 | $0.97 | · | $3.72 | $1.55 | $2.54 | · | $1.57 | |
| Revenue / Share | $1.81 | $1.38 | · | $1.61 | $1.29 | $0.93 | · | $0.81 | $0.70 | $0.54 | · | $0.49 | $0.79 | $0.84 | · | $0.84 | |
| Cash Flow / Share | · | $-0.44 | · | · | · | $-0.48 | · | · | · | $-1.54 | · | · | · | $-1.19 | · | · | |
| Cash / Share | $1.25 | $0.85 | · | $1.24 | $0.84 | $0.70 | · | $0.47 | $0.42 | $0.57 | · | $1.92 | $0.95 | $2.16 | · | $2.36 | |
| EPS (TTM) | $-0.45 | $-0.22 | · | $-1.04 | $-2.02 | $-2.79 | · | $-4.44 | $-1.77 | $-1.99 | · | $-1.46 | $-4.52 | $-4.44 | · | $-4.16 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $591M | $536M | · | $436M | $334M | $274M | · | $203M | $178M | $156M | · | $79M | $70M | $66M | · | $42M | |
| Net Income TTM | $-43M | $-21M | · | $-89M | $-169M | $-227M | · | $-351M | $-146M | $-161M | · | $-87M | $-307M | $-289M | · | $-264M | |
| Market Cap | $5.35B | $2.75B | · | $2.14B | $1.32B | $1.59B | · | $1.09B | $628M | $587M | · | $671M | $1.15B | $1.68B | · | $1.58B | |
| P/E | -126.2 | -135.0 | · | -23.0 | -7.3 | -6.4 | · | -3.2 | -4.6 | -3.9 | · | -6.1 | -3.4 | -5.1 | · | -5.9 | |
| P/S | 9.0 | 5.1 | · | 4.9 | 3.9 | 5.8 | · | 5.4 | 3.5 | 3.8 | · | 8.5 | 16.5 | 25.3 | · | 37.9 | |
| P/B | 218.2 | 27.8 | · | 29.1 | 40.3 | 48.5 | · | -35.8 | 41.5 | 7.9 | · | 2.4 | 9.9 | 8.9 | · | 15.7 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | 3.9 | · | 66.2 | · | · | |
| P / Cash Flow | · | -68.0 | · | · | · | -37.7 | · | · | · | -4.9 | · | · | · | -20.7 | · | · | |
| Earnings Yield | -0.79% | -0.74% | · | -4.3% | -13.7% | -15.6% | · | -31.7% | -21.5% | -25.8% | · | -16.3% | -29.4% | -19.7% | · | -16.9% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $491M | $233M | $145M | $109M | $132M |
| Betriebsgewinnmarge % | -12.8% | -138.9% | -267.2% | -125.7% | -71.1% |
| Nettoergebnis | $-26M | $-322M | $-111M | $-278M | $-180M |
| Verwässerte EPS | $-0.29 | $-4.08 | $-1.50 | $-4.37 | $-3.01 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 2.7 | 2.1 | 3.5 | 3.4 | 4.7 |
| Quick Ratio | 1.1 | 0.4 | 0.4 | 0.6 | 1.5 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | · | · | $-281M | $-186M | $-20M |
Institutionelle Eigentümer (13F) 341 Einreicher · $5.9B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
341
Gehaltener Wert
$5.9B
Neue Positionen
91
Geschlossene Positionen
27
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 91 (+38 vs. Vorquartal) | 27 (-28 vs. Vorquartal) | 123 (+28 vs. Vorquartal) | 89 (-10 vs. Vorquartal) | -9.6M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $455.653.851 | 8.020.663 | 7,74% | Aktien |
| FMR LLC | $403.158.609 | 7.096.614 | 6,84% | Aktien |
| JANUS HENDERSON GROUP PLC | $339.246.615 | 11.419.586 | 5,76% | Aktien |
| BANK OF AMERICA CORP /DE/ | $259.527.476 | 4.568.341 | 4,41% | Aktien |
| STATE STREET CORP | $241.796.085 | 4.256.224 | 4,10% | Aktien |
| VANGUARD GROUP INC | $241.075.642 | 6.309.229 | 4,09% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $233.414.906 | 4.108.694 | 3,96% | Aktien |
| PERCEPTIVE ADVISORS LLC | $213.183.729 | 3.752.574 | 3,62% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $159.779.000 | 2.812.514 | 2,71% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $145.965.114 | 2.569.356 | 2,48% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $134.773.950 | 2.371.887 | 2,29% | Aktien |
| Rock Springs Capital Management LP | $123.792.910 | 2.179.069 | 2,10% | Aktien |
| Kynam Capital Management, LP | $113.620.000 | 2.000.000 | 1,93% | Aktien |
| Stephens Investment Management Group LLC | $106.536.020 | 1.875.304 | 1,81% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $104.137.218 | 1.833.079 | 1,77% | Aktien |
| EMERALD ADVISERS, LLC | $90.946.334 | 1.600.886 | 1,54% | Aktien |
| ARMISTICE CAPITAL, LLC | $89.335.941 | 1.572.539 | 1,52% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $88.944.917 | 1.565.656 | 1,51% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $87.579.262 | 1.541.617 | 1,49% | Aktien |
| GOLDMAN SACHS GROUP INC | $87.221.587 | 1.535.321 | 1,48% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $87.094.276 | 1.533.080 | 1,48% | Aktien |
| Qube Research & Technologies Ltd | $81.989.896 | 1.443.230 | 1,39% | Aktien |
| D. E. Shaw & Co., Inc. | $81.833.044 | 1.440.469 | 1,39% | Aktien |
| Driehaus Capital Management LLC | $81.757.203 | 1.439.134 | 1,39% | Aktien |
| MARSHALL WACE, LLP | $75.739.490 | 1.333.207 | 1,29% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $65.726.898 | 1.156.960 | 1,12% | Aktien |
| MPM BIOIMPACT LLC | $63.782.348 | 1.122.731 | 1,08% | Aktien |
| Nuveen, LLC | $59.913.701 | 1.054.633 | 1,02% | Aktien |
| EMERALD MUTUAL FUND ADVISERS TRUST | $58.629.283 | 1.032.024 | 1,00% | Aktien |
| JANE STREET GROUP, LLC | $53.327.491 | 938.699 | 0,91% | Aktien |
| NORTHERN TRUST CORP | $49.709.205 | 875.008 | 0,84% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $46.997.663 | 827.278 | 0,80% | Aktien |
| Eversept Partners, LP | $45.389.656 | 798.973 | 0,77% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $37.598.221 | 661.824 | 0,64% | Aktien |
| Ensign Peak Advisors, Inc | $33.621.010 | 591.815 | 0,57% | Aktien |
| Fiera Capital Corp | $29.370.599 | 516.997 | 0,50% | Aktien |
| ARMISTICE CAPITAL, LLC | $28.405.000 | 500.000 | 0,48% | Kaufoption |
| PANAGORA ASSET MANAGEMENT INC | $27.878.030 | 490.724 | 0,47% | Aktien |
| TWO SIGMA ADVISERS, LP | $27.721.355 | 725.500 | 0,47% | Aktien |
| Point72 Asset Management, L.P. | $27.204.037 | 478.860 | 0,46% | Aktien |
| UBS Group AG | $26.897.036 | 473.456 | 0,46% | Aktien |
| LOOMIS SAYLES & CO L P | $26.752.625 | 470.914 | 0,45% | Aktien |
| Legal & General Group Plc | $26.723.424 | 470.400 | 0,45% | Aktien |
| Candriam S.C.A. | $26.690.051 | 470.265 | 0,45% | Aktien |
| Invesco Ltd. | $26.093.685 | 459.315 | 0,44% | Aktien |
| Graham Capital Management, L.P. | $25.376.800 | 446.696 | 0,43% | Aktien |
| MORGAN STANLEY | $24.385.926 | 429.253 | 0,41% | Aktien |
| Assenagon Asset Management S.A. | $24.275.197 | 427.305 | 0,41% | Aktien |
| Russell Investments Group, Ltd. | $22.495.038 | 395.969 | 0,38% | Aktien |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $22.131.322 | 379.611 | 0,38% | Aktien |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Opaleye L.P ×3 Einreichungen | 5. Juni 2015 | · | Erste Einreichung | · | SEC |
| MSMB Capital Management LP, MSMB Capital Management LLC, MSMB Healthcare LP, MSMB Healthcare Investors LLC, MSMB Healthcare Management LLC, Martin Shkreli ×2 Einreichungen | 19. Februar 2013 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 29 Insider · 14 Führungskräfte · 13 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Eric M Dube | CHIEF EXECUTIVE OFFICER | 17. September 2026 M | 432.886 | 0 | 21 | $-41.345.901 |
| Christopher R. Cline | CHIEF FINANCIAL OFFICER | 15. September 2026 M | 87.508 | 0 | 15 | $-4.644.621 |
| Laura Clague | Chief Financial Officer | 11. Mai 2022 S | 35.655 | 0 | 0 | $0 |
| Marc L Panoff | Chief Financial Officer | 24. Februar 2014 A | 221.100 | 0 | 0 | $0 |
| Neil F. Mcfarlane | Chief Operating Officer | 16. Mai 2019 S | 26.988 | 0 | 0 | $0 |
| Peter Heerma | EVP, CHIEF COMMERCIAL OFFICER | 17. September 2026 M | 117.066 | 0 | 13 | $-18.970.991 |
| William E. Rote | Chief Research Officer | 16. September 2026 M | 98.197 | 0 | 10 | $-16.427.375 |
| Jula Inrig | EVP, Head of R&D & CMO | 15. September 2026 M | 100.491 | 0 | 15 | $-5.155.138 |
| Sandra Calvin | SVP, CHIEF ACCOUNTING OFFICER | 15. September 2026 M | 42.353 | 0 | 8 | $-4.193.777 |
| Elizabeth E Reed | Chief Legal Officer and GC | 15. September 2026 M | 105.389 | 0 | 19 | $-7.016.278 |
| Noah L. Rosenberg | Chief Medical Officer | 17. August 2021 S | 47.614 | 0 | 0 | $0 |
| Alvin Shih | EVP of Research & Development | 1. September 2016 S | 158.334 | 0 | 0 | $0 |
| VALEUR JENSEN MARGARET E | General Counsel | 1. Februar 2016 A | 100.000 | 0 | 0 | $0 |
| Horacio Plotkin | Chief Medical Officer | 12. Dezember 2014 S | 91.767 | 0 | 0 | $0 |
| Jeffery A. Meckler | Direktor | 10. September 2026 M | 91.500 | 0 | 5 | $-1.706.062 |
| LYONS GARY A | Direktor | 18. August 2026 M | 61.500 | 0 | 6 | $-961.428 |
| Roy D. Baynes | Direktor | 12. Juni 2026 M | 41.500 | 0 | 6 | $-2.548.200 |
| Timothy Coughlin | Direktor | 12. Juni 2026 M | 56.250 | 0 | 3 | $-1.272.582 |
| Sandra Poole | Direktor | 19. Mai 2026 A | 34.000 | 0 | 0 | $0 |
| Suzanne Louise Bruhn | Direktor | 19. Mai 2026 A | 32.750 | 0 | 0 | $0 |
| John A Orwin | Direktor | 19. Mai 2026 A | 39.375 | 0 | 0 | $0 |
| Ron Squarer | Direktor | 19. Mai 2026 A | 39.375 | 0 | 0 | $0 |
| Steve Aselage | Direktor | 11. Mai 2022 S | 146.919 | 0 | 0 | $0 |
| John W Kozarich | Direktor | 8. Mai 2019 A | 29.000 | 0 | 0 | $0 |
| Steven Gary Richardson | Direktor | 21. November 2014 P | 129.165 | 0 | 0 | $0 |
| Jeffrey Paley | Direktor | 14. August 2014 S | 51.665 | 0 | 0 | $0 |
| Ruth Williams Brinkley | · | 19. Mai 2026 A | 29.750 | 0 | 0 | $0 |
| Cornelius E Golding | · | 18. Mai 2016 A | 29.000 | 0 | 0 | $0 |
| Martin Shkreli | · | 12. September 2014 J | 1.765.168 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 40 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PJP · Invesco Exchange-Traded Fund Trust | 2,82% | 266.816 SH | 1. Oktober 2026 | Täglich |
| SPIT · RBB Fund, Inc. | 2,66% | 15.858 NS | 31. Juli 2026 | N-PORT |
| PTH · Invesco Exchange-Traded Fund Trust | 2,17% | 135.318 SH | 1. Oktober 2026 | Täglich |
| BBP · ETFis Series Trust I | 1,48% | 26.078 NS | 31. Juli 2026 | N-PORT |
| GURU · Global X Funds | 1,42% | 15.557 NS | 31. Juli 2026 | N-PORT |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,85% | 37.745 SH | 1. Oktober 2026 | Täglich |
| LABU · Direxion Shares ETF Trust | 0,82% | 72.196 NS | 31. Juli 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,67% | 154.467 NS | 31. Juli 2026 | N-PORT |
| SAWS · ETF Series Solutions | 0,58% | 810 NS | 31. Juli 2026 | N-PORT |
| BRNY · EA Series Trust | 0,49% | 51.173 NS | 31. Juli 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,45% | 31.511 SH | 1. Oktober 2026 | Täglich |
| IBB · iShares Trust | 0,45% | 691.376 SH | 11. September 2026 | Täglich |
| IWO · iShares Trust | 0,40% | 839.091 SH | 11. September 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,36% | 6.674 SH | 1. Oktober 2026 | Täglich |
| ESSC · Strategy Shares | 0,31% | 2.023 NS | 31. Juli 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,31% | 76.777 NS | 31. Juli 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,30% | 95.695 SH | 19. August 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,23% | 986 NS | 31. Juli 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,22% | 3.427 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,21% | 29.359 SH | 11. September 2026 | Täglich |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,20% | 25.221 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,20% | 2.285.414 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,16% | 42.807 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,15% | 514.614 SH | 19. August 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,14% | 13.993 NS | 31. Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,11% | 50.798 SH | 1. Oktober 2026 | Täglich |
| VFMO · VANGUARD WELLINGTON FUND | 0,11% | 37.027 SH | 19. August 2026 | Täglich |
| ESML · iShares Trust | 0,10% | 40.314 SH | 11. September 2026 | Täglich |
| FBCG · FIDELITY COVINGTON TRUST | 0,09% | 105.982 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,07% | 249.426 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,07% | 39.446 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,06% | 1.066.102 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,05% | 4.919 SH | 11. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 2.948.502 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 7.348 SH | 19. August 2026 | Täglich |
| ITOT · iShares Trust | 0,01% | 124.076 SH | 11. September 2026 | Täglich |
| IWV · iShares Trust | 0,01% | 22.530 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,01% | 2.004 NS | 31. Juli 2026 | N-PORT |
| ISCB · iShares Trust | · | 4.157 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 46.599 SH | 11. September 2026 | Täglich |
TVTX Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 21 Analysten
KAUF
Median-Ziel
$75.50
+32,6%
8 38,1%
Starker Kauf
11 52,4%
Kauf
2 9,5%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
14 Analysten · 2026-10-02Mittelwert-Ziel $75.21 +32,1%
← Unter allen Zielen
Aktueller Preis $56.93
Tief$62.00
Mittelwert$75.21
Hoch$90.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| TVTX | $3.47B | -131.8 | 110.5% | -5.2% | -34.6% | · |
| KOD | $1.73B | -6.5 | · | · | -202.0% | · |
| SRRK | $4.78B | -13.4 | · | · | -157.9% | · |
| ORKA | $1.48B | -3.3 | · | · | -25.9% | · |
| MIRM | $4.10B | -168.1 | 54.7% | -4.5% | -8.2% | · |
| COGT | $5.72B | -16.4 | · | · | -83.1% | · |
| PTCT | $6.19B | 9.8 | 114.5% | 39.4% | -331.5% | · |
| ERAS | $1.06B | -8.5 | · | · | -35.7% | · |
| DNTH | $1.78B | -9.8 | -67.3% | -7973.3% | -40.8% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 4, 2026